ARCHIVES

In Brief: Upton Okays Laetrile Clinical Trials, To Seek Protocols From Clinicians For IND Request

This article is from The Cancer Letter archive.

Vol. 04 No. 40 | October 6, 1978

Download PDF Visit The Full Archive

Related Articles

Rauscher Says He May Leave, But Will Stay Through June

February 6, 1976

In Brief: Hopkins Wins SPORE in Gastointenstinal Cancers; Nurses Group Calls For Proposals

January 21, 1994

In Brief: NCI To Move Todaro’s Lab to FCR; Cinnamyl Anthranilate Was Carciogenic In Bioassay

March 28, 1980

More Changes In Carcinogenesis Program At NCI: Gori, Workshops Out, Branch Chiefs Running It

November 18, 1977

DePinho Will Not Meet With AAUP In Probe of Tenure Denial Dispute

September 19, 2014

FDA approves a new cancer drug, Vidaza, and two sNDAs, without going to ODAC. A date with ODAC may signal a weak case for drug approval, recent approval data indicate.

May 28, 2004